Stocks remained in positive territory breaking a three-day losing streak ahead of U.S. corporate earnings this week, despite mounting tension between North Korea and the U.S. The financial sector led markets higher. Netflix (NFLX) shares rose Monday as the streaming company is expected to report earnings of 37 cents a share on revenue of $2.64 billion after the closing bell. Eli Lilly (LLY) shares dropped, while Incyte's (INCY) shares tumbled after the company's joint application for the once-daily oral medication for the treatment of moderate-to-severe rheumatoid arthritis, was rejected by the Food and Drug Administration. Finally, OncoMed Pharmaceuticals (OMED) dropped over 17% after the bio-pharmaceutical company said the phase 2 trial of its drug for small cell lung cancer, didn't meet its primary or secondary endpoints.
More from Video
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.